Propeller Health’s ‘My Pharmacy’ Links COPD Patients to Walgreens’ Pharmacists
Walgreens is the first pharmacy to participate in a new service that connects people with chronic obstructive pulmonary disease (COPD) or asthma to pharmacy services. Launched by digital therapeutics company Propeller Health, the My Pharmacy feature aims to offer users a sole platform for managing their treatment regimen.
The service is part of the Propeller mobile app, and is available on iOS for Propeller users, and will be available on Android soon. The feature will be extended to other programs and pharmacies this year.
My Pharmacy will enable patients to refill prescriptions, find the closest Walgreens, speak with a pharmacist through Walgreens Pharmacy Chat, and get updates on Walgreens Balance Rewards points.
Through Walgreens Pharmacy Chat, patients are able to have confidential, secure conversations with pharmacists, get free expert advice online, and print or email chat transcripts for reference.
“Our collaboration with Propeller is the latest example of our focus on working with healthcare companies to bring new, innovative services to our patients and customers,” Giovanni Monti, vice president and director of healthcare innovation, Walgreens Boots Alliance, said in a press release.
“The ability to refill a prescription or talk to a pharmacist through an existing digital health tool is an important step in making care easier, faster and less stressful for patients,” said Greg Tracy, chief technology officer for Propeller Health. “We’re thrilled to work with Walgreens on this launch and hope our collaboration will serve as a blueprint for future pharmacy integrations within our platform.”
Propeller Health creates products to treat chronic respiratory diseases and improve clinical outcomes for patients through connectivity, analytics, and digital experiences. The Propeller digital solution is based on sensors attached to a person’s inhaler and a proprietary software platform that can be used as a mobile app.
The platform is used by patients, physicians, and healthcare organizations in the U.S., Europe and Asia.